Production of spirobisnaphthalenes

Production of spirobisnaphthalenes refers to the biosynthetic or chemical synthesis of a distinct class of fungal secondary metabolites characterized by two naphthalene-derived units joined by a spiroketal or spiroether linkage. These compounds, which include the palmarumycins, diepoxins, and preussomerins, are produced by various endophytic and coprophilous fungi via the pentaketide pathway. While the molecules generated by this production process are of high interest in drug discovery due to their diverse biological activities—such as antibacterial, antifungal, and potent antitumor effects—the 'production' itself is a complex metabolic sequence and not a single protein, receptor, or enzyme target. Specifically, many spirobisnaphthalenes act as inhibitors of key therapeutic enzymes like thioredoxin reductase (TrxR) and phospholipase C (PLC), making them valuable lead compounds for oncology research. However, because the input describes a biological assembly process or synthetic methodology rather than a discrete molecular target, it is classified as incorrect in the context of therapeutic target identification.

Other names

Spirobisnaphthalene biosynthesisSpirobisnaphthalene synthesisFungal spirobisnaphthalene metabolic pathway

Not applicable as this refers to a biosynthetic process rather than a therapeutic target molecule.